CAS: 476-28-8; (1S,2S,3A1S,12Bs)-2,3A1,4,5,7,12B-Hexahydro-1H-[1,3]Dioxolo[4,5-J]Pyrrolo[3,2,1-De]Phenanthridine-1,2-Diol

该化合物是一种天然产生的藻类,主要来自阿玛利利里达塞埃家族的植物,特别是精液,以其结构复杂性而闻名,具有苯丙胺骨质; 液态展示了一系列生物活动,包括抗病毒,抗菌和抗癌特性,使其成为药理学研究的一个主题; 化合物已证明抑制蛋白合成,有助于其潜在的治疗效果; 液态通常存在于各种植物部件中,包括灯泡和叶叶,并经常研究其对细胞过程的影响; 其溶解性特征各异,在有机溶剂中通常溶解,但水溶解程度较低; 由于其生物活性性质,盐也与高浓度的毒性有关,因此需要在研究和潜在的药用应用中谨慎处理和剂量考虑.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号69787-57-1 1-acetyl-2-chlo... | CAS号2492-05-9 1,2-Diacetoxyly... | CAS号6391-78-2 (1S,2S,3a(1)S,1... | CAS号7344-73-2 1-Acetoxylycorine | CAS号58700-92-8 1α-hydroxy-9,10... | CAS号58700-89-3 α-dihydrolycori... | CAS号58700-93-9 (1S,2S,3a(1)S,1... | CAS号71635-31-9 9,10-methanediy... | CAS号40360-71-2 Anhydrolycorinone | CAS号641-89-4 anhydrolycorine | CAS号40141-98-8 5-methyl-[1,3]d...

合成工艺路线路线简述

    📜1α-Hydroxy-9,10-Methanediyldioxy-Galanth-2-En-7-One置于lithium Aluminium Tetrahydride,间氯过氧苯甲酸体系中,用 四氢呋喃,吡啶,氯仿 作为反应溶剂,化学反应生成 石蒜碱
    参考文献:Tsuda,Y. Et Al.,Journal Of The Chemical Society. Perkin Transactions I,1979,P. 1358-1363
    标题:Tsuda,Y. Et Al.,Journal Of The Chemical Society. Perkin Transactions I,1979,P. 1358-1363

    海关参考信息

    专利信息


    专利号:WO-2023241716-A1
    优先权日:2022-06-16
    标 题 :Method for inducing in-situ regeneration of mammal and use thereof
    发明人:LI WEI; ZHOU QI; He zheng-quan; YUAN XUEWEI; LU ZONGBAO; WANG XIN; WANG SHUAI; LI YUFEI; WANG LIU
    权利人:INST ZOOLOGY CAS; BEIJING INST FOR STEM CELL AND REGENERATIVE MEDICINE
    摘要:Provided is use of a protein synthesis inhibitor in promoting regeneration and repair capacity of mammal tissues or complex structures or organs. The protein synthesis inhibitor is a small molecule compound, from any of cycloheximide or an Amaryllidaceae extract, capable of promoting regeneration of mammal tissues and organs.

    专利号:US-4214092-A
    优先权日:1979-02-21
    标题:Rearrangement of acyloxy furans and thiophenes prepared from butenolides
    发明人:KRAUS GEORGE A
    权利人:UNIV IOWA STATE RES FOUND INC
    摘要:A method of preparing acyloxy furans and thiophenes from butenolides comprising reacting a pre-selected butenolide with an acylating agent in the presence of a base to provide an acyloxy furan intermediate, which in turn undergoes rearrangement in the presence of Lewis Acids by cleavage of a carbon-oxygen bond, and addition of the cleaved moiety to the furan ring forming a carbon-carbon bond on the ring. The result is a heretofore unknown group of lactone type compounds which are biologically active, in and of themselves, and in addition offer use as versatile synthesis intermediates to achieve, by conventional synthesis methods heretofore unavailable compounds.

    专利号:WO-2009140467-A1
    优先权日:2008-05-15
    标 题:Oxobenzindolizinoquinolines and uses thereof
    发明人:CUSHMAN MARK S; CINELLI MARIS A; MORRELL ANDREW E; POMMIER YVES G
    权利人:PURDUE RESEARCH FOUNDATION; CUSHMAN MARK S; US GOV HEALTH & HUMAN SERV; CINELLI MARIS A; MORRELL ANDREW E; POMMIER YVES G
    摘要:The synthesis of aromathecins, substituted 12 H -5,l la-diazadibenzo[ b,h ]fluoren- 11 -ones is described. Use of these cytotoxic compounds and pharmaceutical compositions containing them for the treatment of cancer is described. Two novel processes for the synthesis of this system and a series of 14-substituted aromathecins as novel cytotoxic, topoisomerase I poisons are described.

    专利号:US-2001024798-A1
    优先权日:1998-06-11
    标题:Biomimetic combinatorial synthesis
    发明人:SHAIR MATTHEW D; LINDSLEY CRAIG W; PELISH HENRY E; SHEEHAN SCOTT M; GOESS BRIAN C; LAYTON MARK E; CHAN LAWRENCE K; CHEN CHUO; WESTWOOD NICHOLAS J
    摘要:The present invention provides biomimetic compounds and libraries thereof, as well as methods for their production. In general, the inventive method involves the selection of a desired biological synthetic pathway and mimics that synthetic pathway utilizing modern synthetic tools. The structures formed from this method are preferably generated in fewer than four steps. These scaffold structures can then be functionalized to yield biomimetic compounds and libraries of compounds. In preferred embodiments, biomimetic compounds and libraries are generated from an oxidative phenolic coupling reaction. In other particularly preferred embodiments, the compounds and libraries of compounds are generated from cascade reactions to yield bicyclo [n. 3.1 ] ring systems, medium ring systems, and fused ring systems. In addition to compounds, libraries and methods for their production, the present invention also provides pharmaceutical compositions and methods and kits for determining one or more biological activities of the library members.

    专利号:WO-2023241717-A1
    优先权日:2022-06-16
    标题:Substance for promoting regeneration and repair of organs of mammals and use thereof
    发明人:LI WEI; ZHOU QI; He zheng-quan; LU ZONGBAO; WANG SHUAI; WANG XIN; YUAN XUEWEI; WANG LIU
    权利人:INST ZOOLOGY CAS; BEIJING INST FOR STEM CELL AND REGENERATIVE MEDICINE
    摘要:Provided is use of a substance capable of up-regulating ISG gene expression in preparing a drug or reagent for promoting the regeneration and repair capacity of tissues or complex structures or organs of mammals. The substance for up-regulating ISG gene expression is selected from one or two or more of an MAPK inhibitor, a retinoic acid receptor-related orphan receptor inhibitor, a protein synthesis inhibitor, and an interferon (IFNγ, β, λ) or alarmin (S100A8/A9) protein. The regeneration and repair refer to promoting the regeneration of tissues or complex structures or organs after tissue or organ resection or damage.

    专利号:US-2011212986-A1
    优先权日:2008-08-21
    标题 :Anti-flavivirus therapeutic
    发明人:SHI PEI-YONG; PUIG-BASAGOITI FRANCESC; PANKIEWICZ KRZYSZTOF W; FELCZAK KRZYSZTOF; CHEN LIQIANG
    权利人:HEALTH RESEARCH INC; UNIV MINNESOTA
    摘要:The present invention relates to anti-flavivirus compounds, including lycorine and derivatives thereof, and their use in treating a subject infected by a flavivirus. The present invention also relates to the use of the anti-flavivirus compounds for the prophylaxis of flavivirus infection. The present invention further relates to a method of suppressing viral RNA synthesis of a flavivirus. Also described is a method of preparing an anti-flavivirus compound for use in the treatment or prophylaxis of flavivirus infection.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Hu M, Peng S, He Y, Qin M, Cong X, Xing Y, Liu M, Yi Z. Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer. Oncotarget. 2015 Jun 20;6(17):15348-61.
    2: Chen D, Cai J, Cheng J, Jing C, Yin J, Jiang J, Peng Z, Hao X. Design, Synthesis and Structure-Activity Relationship Optimization of Lycorine Derivatives for HCV Inhibition. Sci Rep. 2015 Oct 7;5:14972. doi: 10.1038/srep14972.
    3: Luo Y, Roy M, Xiao X, Sun S, Liang L, Chen H, Fu Y, Sun Y, Zhu M, Ye M, Liu J. Lycorine induces programmed necrosis in the multiple myeloma cell line ARH-77. Tumour Biol. 2015 Apr;36(4):2937-45. doi: 10.1007/s13277-014-2924-7. Epub 2014 Dec 7. Chinese. doi: 10.1155/2014/408306. Epub 2014 May 6.

    合成参考文献


    参考文献:10.1007/bf01965794
    摘要:Takaishi Y, Terada H, Fujita T. The effect of two new peptide antibiotics, the hypelcins, on mitochondrial function. Cellular and Molecular Life Sciences. 1980 May;36(5):550–2. doi: 10.1007/bf01965794.
    摘要:Arrigoni O, Paciolla C, De Gara L. Inhibition of galactonolactone dehydrogenase activity by lycorine. Boll Soc Ital Biol Sper. 1996 Jan;72(1-2):37–43.
    参考文献:10.1016/j.bmcl.2008.03.008
    摘要:Berkov S, Codina C, Viladomat F, Bastida J. N-Alkylated galanthamine derivatives: Potent acetylcholinesterase inhibitors from Leucojum aestivum. Bioorganic & Medicinal Chemistry Letters. 2008 Apr;18(7):2263–6. doi: 10.1016/j.bmcl.2008.03.008.
    参考文献:10.1007/s12602-018-9422-y
    摘要:Liu J, Han D, Shi Y. Gene Cloning, Expression, and Antifungal Activities of Permatin from Naked Oat (Avena nuda). Probiotics Antimicrob Proteins. 2019 Mar;11(1):299–309. doi: 10.1007/s12602-018-9422-y.
    参考文献:10.1016/s0021-9258(17)36118-5
    摘要:Vrijsen R, Vanden Berghe DA, Vlietinck AJ, Boeyé A. Lycorine: a eukaryotic termination inhibitor Journal of Biological Chemistry. 1986 Jan;261(2):505–7. doi: 10.1016/s0021-9258(17)36118-5.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知